| Net Cash Provided by (Used in) Operating Activities |
$8,153,590 |
USD |
55% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$34,117,856 |
USD |
|
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$17,866 |
USD |
99% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
36,000,000 |
shares |
-92% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
21,277,037 |
shares |
-33% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$25,946,400 |
USD |
|
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$38,201,743 |
USD |
1077% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Valuation Allowance |
$135,704,699 |
USD |
14% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$135,704,699 |
USD |
14% |
Q4 2024 |
FY 2024 |
| Operating Lease, Liability |
$21,794,812 |
USD |
|
Q3 2025 |
Q3 2025 |
| Payments to Acquire Property, Plant, and Equipment |
$17,866 |
USD |
-99% |
Q1 2025 |
Q1 2025 |
| Lessee, Operating Lease, Liability, to be Paid |
$6,632,840 |
USD |
-19% |
Q4 2024 |
FY 2024 |
| Property, Plant and Equipment, Gross |
$49,299,299 |
USD |
4.8% |
Q4 2024 |
FY 2024 |
| Operating Lease, Liability, Current |
$2,707,209 |
USD |
170% |
Q3 2025 |
Q3 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year Two |
$1,503,069 |
USD |
3% |
Q4 2024 |
FY 2024 |
| Lessee, Operating Lease, Liability, to be Paid, Year One |
$1,458,783 |
USD |
-8.2% |
Q4 2024 |
FY 2024 |
| Operating Lease, Weighted Average Discount Rate, Percent |
0.1 |
pure |
0% |
Q4 2024 |
FY 2024 |
| Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
$1,352,691 |
USD |
-28% |
Q4 2024 |
FY 2024 |
| Lessee, Operating Lease, Liability, to be Paid, Year Three |
$1,316,387 |
USD |
-12% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$118,465,120 |
USD |
14% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
75,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Unrecognized Tax Benefits |
$805,392 |
USD |
0% |
Q4 2024 |
FY 2024 |
| Lessee, Operating Lease, Liability, to be Paid, Year Four |
$1,230,385 |
USD |
-6.5% |
Q4 2024 |
FY 2024 |
| Additional Paid in Capital |
$928,660,494 |
USD |
5.6% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Depreciation, Depletion and Amortization |
$1,982,482 |
USD |
1.1% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$0 |
USD |
|
Q4 2024 |
FY 2024 |
| Share-based Payment Arrangement, Expense |
$3,385,063 |
USD |
-70% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |